AbbVie e Genmab recebem designação de terapia inovadora para tratamento de linfoma folicular recidivante ou refratário

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AbbVie e Genmab recebem designação de terapia inovadora para tratamento de linfoma folicular recidivante ou refratário

/jornal/2023/11/abbvie-e-genmab-recebem-designacao-de-terapia-inovadora-para-tratamento-de-linfoma-folicular-recidivante-ou-refratario/

Abbvie (BOV:ABBV34)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Abbvie Charts.

Abbvie (BOV:ABBV34)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Abbvie Charts.

News

More News Articles

Decentral Life (PK)

Good Vibrations Shoes (PK)

Bioelectronics (PK)

Code Green Apparel (PK)

Virexit Technologies (PK)

Rennova Health (CE)

Moon Equity (PK)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Enanta Pharmaceuticals

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions